Abstract
The concentration of alpha 2HS-glycoprotein (alpha 2HS-GP), as measured by the single radial immunodiffusion technique in the sera of 52 patients with various renal diseases and varying degrees of proteinuria, was found to be significantly reduced (P less than 0.001) when compared to the control values. Out of the 52 patients examined, 34 were found to excrete alpha 2HS-GP in urine with no correlation between the serum and urine levels of this protein. Although there is a statistically significant correlation between the clearances of albumin and alpha 2HS-GP, in only six patients were the clearances of alpha 2HS-GP within +/- 25% of albumin clearance. Twelve had higher, and 16 had lower, relative clearances of alpha 2HS-GP. The relative clearance of alpha 2HS-GP had no relation to the serum levels of alpha 2HS-GP, but correlated with the degree of proteinuria and the type of histological lesion in the kidney. In conclusion, there is a quantitative reduction of serum alpha 2HS-GP in patients with renal diseases. It appears that the degree of proteinuria and the type of renal lesion influences its selective handling by the kidneys.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baskies A. M., Chretien P. B., Weiss J. F., Makuch R. W., Beveridge R. A., Catalona W. J., Spiegel H. E. Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity. Cancer. 1980 Jun 15;45(12):3050–3060. doi: 10.1002/1097-0142(19800615)45:12<3050::aid-cncr2820451229>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Bienenstock J., Poortmans J. Renal clearance of 15 plasma proteins in renal disease. J Lab Clin Med. 1970 Feb;75(2):297–306. [PubMed] [Google Scholar]
- Gejyo F., Schmid K. Purification and characterization of the two forms of human plasma alpha 2HS-glycoprotein. Biochim Biophys Acta. 1981 Nov 30;671(1):78–84. doi: 10.1016/0005-2795(81)90096-9. [DOI] [PubMed] [Google Scholar]
- Lebreton J. P., Joisel F., Raoult J. P., Lannuzel B., Rogez J. P., Humbert G. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest. 1979 Oct;64(4):1118–1129. doi: 10.1172/JCI109551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Melliger E. J. Detection of fibrinogen degradation products by use of antibody coated latex particles. The possibilities and limits of the method. Thromb Diath Haemorrh. 1970 May 31;23(2):211–227. [PubMed] [Google Scholar]
- Schelp F. P., Thanangkul O., Supawan V., Pongpaew P. alpha 2HS-glycoprotein serum levels in protein-energy malnutrition. Br J Nutr. 1980 Mar;43(2):381–383. doi: 10.1079/bjn19800101. [DOI] [PubMed] [Google Scholar]
- Triffitt J. T. Plasma proteins present in human cortical bone: enrichment of the alpha2HS-glycoprotein. Calcif Tissue Res. 1976 Nov 24;22(1):27–33. doi: 10.1007/BF02010343. [DOI] [PubMed] [Google Scholar]
- van Oss C. J., Gillman C. F., Bronson P. M., Border J. R. Opsonic properties of human serum alpha-2 hs glycoprotein. Immunol Commun. 1974;3(4):329–335. doi: 10.3109/08820137409061113. [DOI] [PubMed] [Google Scholar]